There is no organized real estate marketplace for biomanufacturing buildings in the US.
Pathway is King Street’s solution for biotech companies who have decided to manufacture their drugs in-house.
Pathway offers two time saving options which can shorten occupancy timeframes by 8-24 months.
With Pathway, all the time-consuming up-front work is done. Tenants can select either speculatively constructed base building packages or fully permitted, shovel-ready pad sites.
Why King Street
Design Informed by Experience
King Street has specialized in life science real estate for almost 20 years, building lasting partnerships across the industry and helping companies like yours navigate the real estate process.
Biomanufacturing facilities are enormously expensive. King Street's financial strength allows Pathway customers to shift a significant portion of those costs off of their balance sheet, enabling them to focus on what matters most: their product.
Placemaking for Science
We’ve always been committed to creating places that perfectly balance design and function. Our state-of-the-art biomanufacturing facilities provide the production framework suitable for any potential specialized manufacturing use while offering an environment your employees will love coming to every day.